By Sheeba M. | Weedstock Market Desk | Saturday, October 24, 2026 — 7:00 PM ET
Saturday trading wrapped up quietly for cannabis equities, capping a week dominated by Q3 2026 earnings season. Volumes thinned out as the afternoon progressed, but the week’s underlying narrative remained intact: the multi-state operators (MSOs) that managed to hold Florida margins while expanding in newly adult-use states were rewarded, while those still wrestling with execution gaps saw continued pressure.
Where Things Stood at the Close
The cannabis sector as a whole finished the week with mixed signals. Trulieve (TCNNF) and Verano Holdings (VRNOF) led the MSO pack following their respective Q3 releases, both citing better-than-expected adjusted EBITDA margins. Green Thumb Industries (GTBIF) held its multi-week range with no major catalyst — investors appear content waiting for any Q4 guidance update. Curaleaf (CURLF) remained under mild pressure ahead of its anticipated earnings report, with the market pricing in a cautious beat.
On the Canadian side, Tilray Brands (TLRY) and Organigram (OGI) both saw low-volume drift. The LP sector has largely stepped back from center stage as the earnings spotlight stayed on U.S. operators this week. Canopy Growth (CGC) continued its quiet consolidation pattern, with no fresh news to move it either direction.
The Week That Was: Q3 Season in Review
If there is one takeaway from the Q3 2026 earnings season, it is this: the operators with disciplined cost structures and diversified state footprints are pulling away from the pack. Florida’s competitive adult-use market has become the proving ground nobody fully anticipated — the cost to compete is real, but the revenue upside for established license-holders is also materializing faster than some analysts modeled.
Pennsylvania adult-use legalization continues to loom as a major potential catalyst for MSOs with deep operational roots in the state. Several operators referenced Pennsylvania in their earnings calls without providing specific guidance — a signal that internal projections are being run but management teams are waiting for regulatory timelines to firm up before making public commitments.
The SAFER Banking Act narrative resurfaced this week following renewed Congressional discussion. Investors who have been in this sector long enough have seen this movie before, but the current legislative context — with a lame-duck session window opening after November elections — makes the next six to eight weeks genuinely worth watching. A SAFER vote that gains traction would be a near-term catalyst for the entire sector, particularly for operators carrying expensive debt at high rates.
What to Watch Monday
Monday opens what could be a quieter week on the earnings front, but several items deserve attention on the watchlist:
- Curaleaf (CURLF) earnings timing: If the company follows its historical pattern, a report could come early next week. Watch for pre-market guidance or an 8-K-style filing. Any miss on adjusted EBITDA could weigh on the broader MSO sector given Curaleaf’s size and visibility.
- SAFER Banking momentum: Monday political commentary and any post-weekend Congressional statements could either reinforce or cool this week’s optimism. Keep an eye on statements from Senate leadership.
- Florida volume data: Monthly dispensary sales figures from Florida regulators tend to trickle out around the end of October. A strong read would be constructive for operators with heavy Florida exposure — Trulieve most of all.
- Macro backdrop: Cannabis stocks don’t trade in a vacuum. The broader risk-on or risk-off tone Monday morning will set the table. Any major macro event over the weekend — economic data, geopolitical noise — could move the tape before cannabis-specific catalysts get a chance to play out.
Forward-Looking Perspective
The balance of 2026 sets up as a consequential stretch for cannabis equities. Q3 earnings season has given investors a clearer picture of which operators are genuinely performing versus which ones are managing optics. The companies that consistently grow revenue, expand margins, and communicate clearly with their investor base are building credibility that will matter when the next major catalyst arrives — whether that is SAFER, a state adult-use vote, or a DEA scheduling decision.
Investors sitting on the sidelines waiting for a clean regulatory signal may find that the best entry points come before those signals are obvious to everyone. That is not a call to ignore risk — cannabis remains a high-volatility, illiquid sector for most retail participants — but it is a reminder that the stocks that led the last major run in this space moved well before the headlines caught up.
For a running view of stock prices, sector movers, and regulatory tracking across major cannabis tickers, visit the Weedstock cannabis stock tracker. We update it daily with key data points across TCNNF, GTBIF, CURLF, VRNOF, TLRY, OGI, and CGC.
TL;DR: Cannabis stocks closed out a Q3 earnings-heavy week on a quiet Saturday note. MSO leaders Trulieve and Verano held gains; Curaleaf eyes are turning to next week. SAFER Banking buzz and Pennsylvania adult-use positioning remain the headline macro themes. Monday opens with Curaleaf timing, Florida volume data, and legislative momentum all worth watching.
Sheeba M. covers cannabis equity markets, MSO earnings, and U.S. regulatory developments for Weedstock. This article is for informational purposes only and does not constitute investment advice.